U.S. Opioid Crisis: ‘A Lot Needs to be Done’ in 3 Key Areas

June 10, 2019

Robert Kramer, the CEO of Emergent Biosolutions, a biopharmaceutical company responsible for overdose reversal drug Naloxone, laid out three areas that require renewed attention. Read More >>


A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.

We are the leading and unifying voice of addiction-focused treatment programs.

Join Now

Contact Us

Monday - Friday
8:30 am - 4:30 pm Pacific
(closed major holidays)